EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antioxidant, Osteogenic, and Neuroprotective Effects of Homotaurine in Aging and Parkinson’s Disease Models

Arianna Minoia iD, Francesca Cristiana Piritore iD, Silvia Bolognin, João Pessoa iD, Bruno Bernardes de Jesus iD, Natascia Tiso iD, Maria Grazia Romanelli iD, Jens Christian Schwamborn, Luca Dalle Carbonare iD, Maria Teresa Valenti iD

Antioxidants · 21.02.2025 · 14 (3) · 249

DOI: 10.3390/antiox14030249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 21.02.2025. Verfasst von Arianna Minoia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Engineering for the Innovation Medicine, University of Verona, 37100 Verona, Italy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MUR, University of Verona, FCT-Fundação para a Ciência e a Tecnologia (Portugal) and FEDER.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aging is associated with the accumulation of cellular damage due to oxidative stress and chronic low-grade inflammation, collectively referred to as “inflammaging”. This contributes to the functional decline in various tissues, including the brain and skeletal system, which closely interplay. Mesenchymal stem cells (MSCs), known for their regenerative potential and ability to modulate inflammation, offer a promising therapeutic approach to counteract aging-related declines. In this study, we investigated the effects of homotaurine (a small molecule with neuroprotective properties) on MSCs and its effects on osteogenesis. We found that homotaurine treatment significantly reduced reactive oxygen species (ROS) levels, improved MSC viability, and modulated key stress response pathways, including the sestrin 1 and p21 proteins. Furthermore, homotaurine promoted osteogenesis and angiogenesis in zebrafish models by enhancing the expression of critical osteogenesis-associated genes, such as those coding for β-catenin and Runt-related transcription factor 2 (Runx2), and increasing the levels of the kinase insert domain receptor-like angiogenesis marker in aged zebrafish. In Parkinson’s disease models using patient-specific midbrain organoids with the leucine-rich repeat kinase 2 G2019S mutation, homotaurine treatment enhanced β-catenin expression and reduced ROS levels, highlighting its potential to counteract the oxidative stress and dysfunctional signaling pathways associated with neurodegeneration. Our findings suggest that homotaurine not only offers neuroprotective benefits but also holds promise as a dual-target therapeutic strategy for enhancing both neuronal and bone homeostasis in aging and neurodegenerative diseases.

Schlagwörter

Stichwörter der Autor:innen

Parkinson’s diseasehomotaurinemesenchymal stem cellsreactive oxygen species

Autor:innen und Institutionen

  • Department of Engineering for the Innovation Medicine, University of Verona, 37100 Verona, Italy.
  • Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy.
  • Luxembourg Centre for Systems Biomedicine (LCSB), Developmental and Cellular Biology, University of Luxembourg, L-4367 Belvaux, Luxembourg.
  • Department of Medical Sciences and Institute of Biomedicine-iBiMED, University of Aveiro, 3810-193 Aveiro, Portugal.
  • Department of Biology, University of Padova, 35131 Padova, Italy.

ORCID-Profile: Arianna Minoia, Francesca Cristiana Piritore, João Pessoa, Bruno Bernardes de Jesus, Natascia Tiso, Maria Grazia Romanelli, Luca Dalle Carbonare, Maria Teresa Valenti

Förderung

  • MUR
  • University of Verona
  • FCT-Fundação para a Ciência e a Tecnologia (Portugal) and FEDER
  • Department of Neuroscience, Biomedicine and Movement Sciences of the University of Verona
  • FUR LDC of the University of Verona
  • FCT-Fundação para a Ciência e a Tecnologia (Portugal)
  • FEDER

Zitieren

APA

Minoia, A., Piritore, F. C., Bolognin, S., Pessoa, J., Bernardes de Jesus, B., Tiso, N., Romanelli, M. G., Schwamborn, J. C., Dalle Carbonare, L., & Valenti, M. T. (2025). Antioxidant, Osteogenic, and Neuroprotective Effects of Homotaurine in Aging and Parkinson’s Disease Models. Antioxidants, 14(3), 249. https://doi.org/10.3390/antiox14030249

Vancouver

Minoia A, Piritore FC, Bolognin S, Pessoa J, Bernardes de Jesus B, Tiso N, et al. Antioxidant, Osteogenic, and Neuroprotective Effects of Homotaurine in Aging and Parkinson’s Disease Models. Antioxidants. 2025;14(3):249. doi:10.3390/antiox14030249

BibTeX
@article{Minoia2025,
  author = {Minoia, Arianna and Piritore, Francesca Cristiana and Bolognin, Silvia and Pessoa, João and Bernardes de Jesus, Bruno and Tiso, Natascia and Romanelli, Maria Grazia and Schwamborn, Jens Christian and Dalle Carbonare, Luca and Valenti, Maria Teresa},
  title = {Antioxidant, Osteogenic, and Neuroprotective Effects of Homotaurine in Aging and Parkinson’s Disease Models},
  journal = {Antioxidants},
  year = {2025},
  volume = {14},
  number = {3},
  pages = {249},
  doi = {10.3390/antiox14030249}
}
Kostenlos starten →